Fresenius Kabi announced that Epinephrine Injection, USP, is now available in the United States as the first generic version of Epinephrine in a 1mg/1mL vial for U.S. customers.
Epinephrine Injection, USP is a prescription medicine used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock; for emergency treatment of allergic reactions, including anaphylaxis; and for induction and maintenance of mydriasis during intraocular surgery.
“Fresenius Kabi is pleased to offer Epinephrine Injection to our U.S. customers, further demonstrating our continued commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve in line with #FutureFresenius,” said Arunesh Verma, president, Fresenius Kabi Region U.S. and Member, Executive Leadership Team, Fresenius Kabi AG.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!